Abstract:Background Unruptured intracerebral aneurysm wall enhancement (AWE) on vessel wall magnetic resonance imaging scans may be a promising predictor for rupture‐prone intracerebral aneurysms. However, the pathophysiology of AWE remains unclear. To this end, the association between AWE and histopathological changes was assessed in this study. Methods and Results A total of 35 patients with 41 unruptured intracerebral aneurysms who underwent surgical clipping were prospectively enrolled. A total of 27 aneurysms were available for histological evaluation. The macroscopic and microscopic features of unruptured intracerebral aneurysms with and without enhancement were assessed. The microscopic features studied included inflammatory cell invasion and vasa vasorum, which were assessed using immunohistochemical staining with CD68, CD3, CD20, and myeloperoxidase for the former and CD34 for the latter. A total of 21 (51.2%) aneurysms showed AWE (partial AWE, n=7; circumferential AWE, n=14). Atherosclerotic and translucent aneurysms were identified in 17 and 14 aneurysms, respectively. Aneurysm size, irregularity, and atherosclerotic and translucent aneurysms were associated with AWE on univariate analysis ( P <0.05). Multivariate logistic regression analysis showed that atherosclerosis was the only factor significantly and independently associated with AWE ( P =0.027). Histological assessment revealed that inflammatory cell infiltration, intraluminal thrombus, and vasa vasorum were significantly associated with AWE ( P <0.05). Conclusions Though AWE on vessel wall magnetic resonance imaging scans may be associated with the presence of atherosclerotic lesions in unruptured intracerebral aneurysms, inflammatory cell infiltration within atherosclerosis, intraluminal thrombus, and vasa vasorum may be the main pathological features associated with AWE. However, the underlying pathological mechanism for AWE still needs to be further studied. Nonstandard Abbreviations and Acronyms AWE aneurysm wall enhancement MPO myeloperoxidase UIA unruptured intracerebral aneurysm Clinical Perspective What Is New? Aneurysm wall enhancement on vessel wall magnetic resonance imaging scans may be associated with atherosclerotic lesions, inflammatory cell infiltration, intraluminal thrombus, and vasa vasorum in unruptured intracerebral aneurysms. What Are the Clinical Implications? We should consider obtaining vessel wall magnetic resonance imaging scans to better understand the pathological characteristics of unruptured intracerebral aneurysms before treatment. However, the underlying pathological mechanism for aneurysm wall enhancement still needs to be further studied. Intracerebral aneurysms (IAs) are histologically characterized by acute and chronic inflammation and vascular wall structure degeneration. 1 , 2 , 3 Increasingly more unruptured IAs have been incidentally discovered and treated, 4 but most of them may be stable and may never rupture over the course of an individual's lifetime. Given the risk associated with treatment and follow‐up observation, it is necessary to evaluate the rupture risk and distinguish rupture‐prone IAs from those that are stable. IAs may undergo morphological changes before rupture 5 —the current predictors identified are mainly based on the patient and aneurysm characteristics, but these have been proven to have limited predictive value. 6 A good predictor for aneurysm rupture should be easily assessed and can reflect pathological changes in the IA. Recently, it has been reported that aneurysm wall enhancement (AWE) on vessel wall magnetic resonance imaging (MRI) scans, indicating wall inflammation, may reflect the cause of subarachnoid hemorrhage in patients with multiple IAs. 7 This imaging finding is also frequently observ -Abstract Truncated-

Statins may Decrease Aneurysm wall Enhancement of Unruptured Fusiform Intracranial Aneurysms: A high-resolution 3T MRI Study

Aneurysm wall enhancement, atherosclerotic proteins, and aneurysm size may be related in unruptured intracranial fusiform aneurysms

Effect of Statin Treatment on Vasospasm-Related Morbidity and Functional Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis

Quantification of aneurysm wall enhancement in intracranial fusiform aneurysms and related predictors based on high-resolution magnetic resonance imaging: a validation study

Statin Treatment for Unruptured Intracranial Aneurysms Study: a Study Protocol for a Double-Blind, Placebo-Controlled Trial

Relationship Between Aneurysm Wall Enhancement and Conventional Risk Factors in Patients with Unruptured Intracranial Aneurysms: A Black-Blood MRI Study.

Acute statins treatment for aneurysmal subarachnoid hemorrhage might be limited: A systematic review and meta-analysis

Aneurysmal Wall Enhancement and Hemodynamics: Pixel-Level Correlation Between Spatial Distribution

Comparisons between cross-section and long-axis-section in quantification of aneurysmal wall enhancement of fusiform intracranial aneurysms in identifying aneurysmal symptoms

Neutrophil-to-Lymphocyte Ratio Is Associated With Circumferential Wall Enhancement of Unruptured Intracranial Aneurysm

Does it stable? Intracranial aneurysm wall enhancement might be the warning signals: a meta-analysis of observational studies

The value of systemic immune inflammation index, white blood cell to platelet ratio, and homocysteine in predicting the instability of small saccular intracranial aneurysms

Associations between haemodynamics and wall enhancement of intracranial aneurysm

Increased Wall Enhancement Extent Representing Higher Rupture Risk of Unruptured Intracranial Aneurysms.

Analysis of Serum Cholesterol, Statins and Atherosclerotic Plaque in Ruptured and Unruptured Intracranial Aneurysm

Dimethyl fumarate treatment for unruptured intracranial aneurysms: a study protocol for a double-blind randomised controlled trial

Association of Elevated Neutrophil-to-lymphocyte Ratio with Increased Intracranial Aneurysm Stability Scores and Aneurysm Growth.

Integrated metagenomic and metabolomic analysis reveals distinctive stage-specific gut-microbiome-derived metabolites in intracranial aneurysms

A Prospective Follow-up Study on Risk Factors to Predict the Progression of Unruptured Intracranial Aneurysms on Enhanced HR-MRI

Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysms: A Histopathological Evaluation.

Omega-3 fatty acids and intracranial aneurysms: a Mendelian randomization study